0001104659-18-060749.txt : 20181005 0001104659-18-060749.hdr.sgml : 20181005 20181005161939 ACCESSION NUMBER: 0001104659-18-060749 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181005 DATE AS OF CHANGE: 20181005 EFFECTIVENESS DATE: 20181005 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 181110588 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 09-30-2018 09-30-2018 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger (415) 801-8100 Robin L. Praeger San Francisco CA 10-04-2018 0 10 294005108 false INFORMATION TABLE 2 a18-36408_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 2991481 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 12018432 1084696 SH OTR 0 1084696 0 Achaogen, Inc. Common Stock 004449104 5111796 1281152 SH OTR 0 1281152 0 Second Sight Medical Products, Inc. Common Stock 81362J100 8536653 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 15241842 2215384 SH OTR 0 2215384 0 Audentes Therapeutics, Inc. Common Stock 05070R104 47690708 1204615 SH OTR 0 1204615 0 ImmuneDesign Corp. Common Stock 45252L103 7618325 2208210 SH OTR 0 2208210 0 CRISPR Therapeutics AG Common Stock H17182108 160053562 3608874 SH OTR 0 3608874 0 OpGen, Inc. Common Stock 68373L109 207399 102167 SH OTR 0 102167 0 Veracyte, Inc. Common Stock 92337F107 34534911 3616221 SH OTR 0 3616221 0